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Abstract. Chronic inflammation is known to play a critical
role in cancer development and progression. High salt is known
to mediate several chronic inflammatory diseases including
hypertension, myocardial infarction, neurological ischemic
attack, autoimmune diseases and cancers. High salt level is
shown to induce angiogenesis and immune-dysfunction, both
of which play a direct role in cancer proliferation. Furthermore,
salt has been suggested to enhance Warburg-like metabolic
phenotype in cancer cells and at the same time also induce
pro-tumor MΦ2-macrophage phenotype. Recent studies have
identified several molecular targets such as tonicity specific
transcript factor NFAT5/TonEBP, sodium ion channel γENaC,
and vascular endothelial growth factor, VEGF, which are
upregulated under high salt external environment. These
molecular targets offer futuristic therapeutic application in
precision medicine. In this review, we discuss the current
understanding of the salt mediated metabolic and immune
dysfunctions playing a potential role in cancerous changes.
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Introduction
Cancer is known to have multi-factorial etiology. Malignant
transformation of terminally differentiated cells is characterized
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by several key hallmarks that directly or indirectly lead to
uncontrolled cell proliferation, reduced cell death, enhanced
angiogenesis and metastatic potential (1,2). Along with these
more recently chronic inflammation is a well-recognized
hallmark of cancer which is interestingly both a cause and
effect of malignant transformation (3). The genetic events
causing malignant transformation also initiate the expression of
inflammation-related machinery that leads to development of a
tumor inflammatory mileu (4). Oncogenes such as RAS, MYC,
and tyrosine kinases are known to induce proinflammatory
cytokines and angiogenic signals (5). Conversely, chronic
inflammation caused by carcinogens and infections is also
known to induce the malignant genetic changes.
Epidemiologic studies increasingly support the notion that
a strong positive correlation exits between chronic inflammatory diseases and risk of cancer development. Several
critical molecular targets such as inducible nitric oxide
synthase (iNOS), nuclear factor κB (NF-κB) and hypoxiainducible factor-1α (HIF-1α), have been identified to mediate
the secretion of inflammatory cytokines (Fig. 1) that either
directly or indirectly induce carcinogenesis (6). Although
several inflammatory causes for cancers have been suggested
environmental and dietary link is well established (7). High
salt diet is well known to induce a pro-inflammatory cascade
leading to chronic inflammatory diseases such as hypertension,
myocardial infarction, neurological transient ischemic attack
and cancer (8,9). While the exact magnitude of salt-intake
needed to induce inflammatory diseases is yet to be defined,
however a cellular and immune dysregulation mediated by salt
and potentially leading to cancer is well established and will
be discussed in this review.
2. Impact of salt on cancer metabolism
Role of inflammatory sodium ion channels. An intratumor
high salt concentration was demonstrated in early 1980s, when
researchers demonstrated that the sodium content of breast
tumors is significantly higher compared to a normal lactating
breast epithelium (10). In these original studies it is unclear if
the tumor activity is directly correlated with high intratumor
salt concentration or if the high sodium concentration is extracellular or intracellular. Regardless, salt is known to induce
inflammation. One of the well realized inflammatory markers,
inducible nitric oxide synthases (iNOS) is shown to be upregu-
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Figure 1. Synergistic pro-inflammatory effect of high salt and IL-17.

lated in several cancers including breast cancers (11). Our
cellular studies on breast cancer cell lines MDA-MB-231 and
MCF7 have shown that high sodium chloride concentration
(0.05 M above basal level) was able to induce the production
of reactive nitrogen and oxygen species (RNS/ROS) (12).
Importantly an equimolar addition of mannitol to the media
did not induce similar effect, thus suggesting sodium play a
direct pro-inflammatory effect on breast cancer cell lines.
Furthermore, earlier studies in 1980s in brain cancers have
shown that an intracellular influx of sodium ions induced
cancerous cell proliferation (13,14). An increasing number of
studies have shown that epithelial sodium channel (ENaC)
which controls the intracellular entry of sodium ions is correlated with cancerous cell changes including, uncontrolled
cell proliferation, anti-apoptosis and cell migration. Studies
by Bondarava et al have demonstrated that ENaC played a
critical role in the sodium induced cell proliferation of HepG2
cells (15). In line with this evidence, recent studies from
our laboratory (Fig. 1) have demonstrated increased sodium
concentration specifically induced upregulation of γENaC
in the breast cancer cell lines and enhanced cellular proliferation (12). It is of interest to note that, the ENaC expression
levels in breast cancer cell lines were upregulated by the
mineralo-corticoid hormone aldosterone, known to control
ionic equilibrium and not glucocorticoid steroid hormones
(16). All these data suggest a direct functional role of ENaC in
high‑sodium induced cancerous development.
Role of salt in Warburg-metabolism. In a terminally differentiated cell, under normoxic conditions, glucose metabolism
by mitochondrial oxidation yields 36-38 ATP. However, a
cancerous cell under similar normoxic conditions, yields
2 ATP with subsequent metabolism of glucose to lactate. This
aberrant behavior of cancerous cells is called aerobic glycolysis or Warburg effect named after the scientist Otto Warburg
who originally discovered this phenomena in 1923 (17). This
glycolytic switch in cancer cells has been used to explain their
extraordinary ability to tolerate hypoxia and inflammatorystress. Furthermore, this glycolytic switch converts a catabolic
glucose metabolism producing carbon dioxide to anabolic
glucose metabolism resulting in higher lipid biosynthesis

needed for cancerous cell proliferation (18). Osmotic stress
induced by hyertonic saline has been suggested to induce
Warburg-like effect by enhancing glucose transport and lactic
acidosis in cancer cells (19). In line with these findings, our
recent studies have demonstrated that high salt in the external
environment induced Warburg-like effect of increased glucose
consumption and lactic acid production in breast cancer cells
(Fig. 2), which was abrogated by anti-inflammatory compound
oleanolic acid (20). Taken together, these data suggest that
high sodium plays a direct role in inducing cancerous metabolic phenotype.
Role of high salt in angiogenesis. Increased formation of
new blood vessels to the newly formed tumor to support its
growth and metabolism is considered as one of the important
hallmarks of cancer development. Vascular endothelial growth
factor (VEGF) is known to induce angiogenesis to tumors
through activation of cancer-specific AKT/PI3k signaling
mechanism (21). Recently strategies targeted against VEGF
have been utilized in anticancer therapies (22). Our recent
studies have demonstrated that high salt directly induces
the expression of VEGF in breast cancer cells through the
transcription factor (Fig. 3), nuclear factors of activated
T cells or NFAT5 signaling (23). The NFAT5 also known as
tonicity-responsive enhancer binding protein (TonEBP) is a
well-established osmotic response element binding protein
known to regulate intracellular osmotic tonicity (24). The
NFAT5 is shown to exert a critical role in immune functioning
and lymphocyte differentiation (25). Gene expression studies
by Remo et al (26) on breast cancer patients (n=197) have
suggested a strong positive correlation between the expression
of NFAT5 and inflammatory breast cancer. These accumulating data clearly suggest that high salt mediates a direct
pro-angiogenic response in the tumor mileu.
3. Impact of salt on macrophages
The innate myeloid lineage macrophages play a critical role of
antigen presentation and immune homeostasis. These terminally differentiated cells uniquely demonstrate a high degree
of plasticity in response to changes in microenvironment.
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Figure 2. Enhanced Warburg-like phenomenon by high salt on cancer cells.

Figure 3. Potential synergistic effect of NFAT5 and STAT3 on cancer angiogenesis.

Two well recognized phenotypes of tissue-resident macrophages are classically activated pro-inflammatory type 1
macrophages (M1) and the alternatively-activated immunosuppressive type 2 macrophages (M2) (27). Various factors
have been implicated in the phenotype switch of macrophages.
The anti-inflammatory M2 phenotype is well established to
be a resident phenotype in tumor TAMs (tumor associated
macrophages) are shown to be negatively correlated with
cancer prognosis. One of the signature cytokines released
from TAMs is interleukin-10.
Studies in our laboratory have demonstrated that treatment
with high salt in the culture media induced specific differentiation of peripheral blood mononuclear cells to M2 phenotype
(CD11b+CD14lowCD16+). As tumors are known to have high
salt microenvironment (28), our data strongly suggest that
high salt induces anti-inflammatory M2 phenotype which are
predominantly accumulated in tumor microenvironment (29).
The cytokine array expressed in the tumor microenvironment

is known to plays a critical role in the activation and differentiation of newly migrated mononuclear phagocytes (30).
While, the M1 phenotype is induced by the cytokines interferon γ (IFNγ) and tumor necrosis factor α (TNFα) (31), the
alternatively activated immune-suppressive TAM phenotype
is induced by transforming growth factor β (TGFβ) in the
cancer microenvironment (32). An important dissimilarity
between MΦ1 and M2 phenotypes is their cytokine pattern.
The M1 phenotype secrets inflammatory cytokines (IL6,
IL-1β and TNFα) that are antitumor, while, M2 phenotype
secretes pro-tumor IL-10, and VEGF (9). However, it seems
the differentiation of tissue resident macrophages is also
site-specific. Studies by Jantsch et al have demonstrated that,
high salt activation macrophage induced an M1 phenotype
switch offering protection against protozoan Leishmania skin
infection (33). These data suggest that the high salt mediated
activation of macrophage is tissue-specific and dependent on
resident microenvironment.
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Figure 4. Pro-tumor effects of high salt mediated immune-modulation in tumor microenvironment.

4. Impact of salt on CD4+ T cells
Local tumor inflammatory mileu is known to recruit several
immune cells including CD4+ T helper (Th) lymphocytes. A
subset of Th-cells which secrets a pro-inflammatory cytokine
IL-17 is well established and is called Th17 phenotype (34).
Several pre-clinical human cancer studies have demonstrated
increased frequency of Th17 cells in the tumor infiltrating
lymphocytes in several solid organ tumors (35,36). The secretion of chemokines, MCP-1 and RANTES, by tumor resident
fibroblasts have been suggested to play a key role in the
recruitment of Th17 cells into the tumor (37). Along with these
chemokines several other factors released by tumor cells such
as Aryl hydrocarbon receptor (AhR) ligands, adenosine, and
metabolites from hypoxia have been suggested to induce Th17
differentiation of naïve CD4+ Th cells in the tumor microenvironment (38,39). Furthermore, the newly recruited Th17
cells have been suggested to further induce tumor growth and
metastasis (Fig. 4). Specifically, IL-17 has been demonstrated
to induce pro-angiogenic VEGF in the tumor mileu leading to
enhanced tumorigenicity and metastasis (40).
While, the precise mechanisms causing the Th17 differentiation in the tumor microenvironment are unclear, one possible
hypothesis would be the possibility of high salt in the tumor
microenvironment might influence differentiation of naïve CD4+
T cells to Th17 phenotype. A very important indirect evidence
to this effect, has been provided by Wu et al, where under
in vitro conditions the researchers demonstrated that high salt
in the culture media induced Th17 differentiation of naïve CD4+
T cells (41). In this study the authors have identified a salt-sensing
transcription factor, serum-glucocorticoid kinase (SGK1), as the
principal molecule it induces salt-specific differentiation to Th17
phenotype. The SGK1 knockdown in these experiments failed
to induce salt-mediated Th17 differentiation.
Immunologically regulatory T cells (Tregs) have been
shown to exert an antagonistic effect on Th17 differentiation
and its molecular downstream effector function. The Treg cells
are known to exert anti-inflammatory effects through secretion
of immune-suppressive IL-10 cytokine. To further consolidate
the notion that salt induces Th17 differentiation, studies by

Hernandez et al, demonstrated that high salt exerts inhibitory
effect on the suppressive activity of Treg (42). In these studies,
researchers demonstrated that the exposure of Treg to high salt
inhibited the suppressive function along with increase in the
pro-inflammatory factors such as IFNG, TBX21 and CXCR3.
Furthermore, under these conditions there was an increase
in the inflammatory IL-17 transcript confirming the studies
by Wu et al (41) mentioned above. Furthermore, utilizing a
humanized mouse model of graft versus host disease (GvHD)
and a murine model of experimental colitis, Hernandez et al
have shown that high salt induced an inflammatory CD4+ T
cell immunophenotype and worsening of the disease (42).
However, a direct study on the role of salt on the tumor will be
needed to confirm the effect of salt on tumors.
5. Future perspectives
High salt diet is known to be the key culprit in several chronic
inflammatory diseases including cardiovascular disease, cancer
and autoimmune diseases. A typical adult Western diet contains
10-12 g sodium per day which is 2-3 times above the WHO
recommended 4.8 g of sodium per day (43). Several epidemiological studies have conclusively supported a positive correlation
between salt and cancer. A wide-spread awareness on saltrestricted diet might be able to reduce the community disease
load. Recent pre-clinical and clinical studies have identified
several molecular targets which mediate salt‑induced damage.
These molecular targets could offer novel futuristic intervention
treatment strategies for personalized precision medicine.
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